Biotech · Private company
Rare Thyroid Therapeutics International AB
Track this companyFree. Adds Rare Thyroid Therapeutics International AB to your Dealase workspace and tells you when its record changes.
Clinical trials31 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- TiratricolPhase 3 · Monocarboxylate Transporter 8 DeficiencyClinicalTrials.gov · fetched Nov 12, 2026
- TiratricolPhase 2 · Allan-Herndon-Dudley SyndromeClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Withdrawal of Tiratricol Treatment in Males With Monocarboxylate Transporter 8 Deficiency (MCT8 Deficiency)PHASE3 · COMPLETED · started Jul 21, 2023ClinicalTrials.gov NCT05579327 · fetched Nov 12, 2026
- Triac Trial II in MCT8 Deficiency PatientsPHASE2 · ACTIVE_NOT_RECRUITING · started Dec 7, 2020ClinicalTrials.gov NCT02396459 · fetched Nov 12, 2026
- Expanded Access Program for Tiratricol in Patients With Monocarboxylate Transporter 8 DeficiencyAPPROVED_FOR_MARKETINGClinicalTrials.gov NCT05911399 · fetched Nov 12, 2026